Both p53 and gemcitabine show tumor growth suppression activity owing to their induction and regulation of apoptosis and thus we checked the mRNA levels of the pro and anti-apoptotic transcription factor as well as downstream apoptotic protein expression in the treated tumors. The gene discussed is TP53; the disease is neoplasm.